Cargando…

Current status of hereditary breast and ovarian cancer practice among gynecologic oncologists in Japan: a nationwide survey by the Japan Society of Gynecologic Oncology (JSGO)

OBJECTIVE: The practices pertaining to hereditary breast and ovarian cancer (HBOC) in Japan have been rapidly changing owing to the clinical development of poly(ADP-ribose) polymerase inhibitors, the increasing availability of companion diagnostics, and the broadened insurance coverage of HBOC manag...

Descripción completa

Detalles Bibliográficos
Autores principales: Kobayashi, Yusuke, Masuda, Kenta, Hiraswa, Akira, Takehara, Kazuhiro, Tsuda, Hitoshi, Watanabe, Yoh, Oda, Katsutoshi, Nagase, Satoru, Mandai, Masaki, Okamoto, Aikou, Yaegashi, Nobuo, Mikami, Mikio, Enomoto, Takayuki, Aoki, Daisuke, Katabuchi, Hidetaka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology; Japan Society of Gynecologic Oncology 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9428299/
https://www.ncbi.nlm.nih.gov/pubmed/35882604
http://dx.doi.org/10.3802/jgo.2022.33.e61
_version_ 1784779084248645632
author Kobayashi, Yusuke
Masuda, Kenta
Hiraswa, Akira
Takehara, Kazuhiro
Tsuda, Hitoshi
Watanabe, Yoh
Oda, Katsutoshi
Nagase, Satoru
Mandai, Masaki
Okamoto, Aikou
Yaegashi, Nobuo
Mikami, Mikio
Enomoto, Takayuki
Aoki, Daisuke
Katabuchi, Hidetaka
author_facet Kobayashi, Yusuke
Masuda, Kenta
Hiraswa, Akira
Takehara, Kazuhiro
Tsuda, Hitoshi
Watanabe, Yoh
Oda, Katsutoshi
Nagase, Satoru
Mandai, Masaki
Okamoto, Aikou
Yaegashi, Nobuo
Mikami, Mikio
Enomoto, Takayuki
Aoki, Daisuke
Katabuchi, Hidetaka
author_sort Kobayashi, Yusuke
collection PubMed
description OBJECTIVE: The practices pertaining to hereditary breast and ovarian cancer (HBOC) in Japan have been rapidly changing owing to the clinical development of poly(ADP-ribose) polymerase inhibitors, the increasing availability of companion diagnostics, and the broadened insurance coverage of HBOC management from April 2020. A questionnaire of gynecologic oncologists was conducted to understand the current status and to promote the widespread standardization of future HBOC management. METHODS: A Google Form questionnaire was administered to the members of the Japan Society of Gynecologic Oncology. The survey consisted of 25 questions in 4 categories: respondent demographics, HBOC management experience, insurance coverage of HBOC management, and educational opportunities related to HBOC. RESULTS: A total of 666 valid responses were received. Regarding the prevalence of HBOC practice, the majority of physicians responded in the negative and required human resources, information sharing and educational opportunities, and expanded insurance coverage to adopt and improve HBOC practice. Most physicians were not satisfied with the educational opportunities provided so far, and further expansion was desired. They remarked on the psychological burdens of many HBOC managements. Physicians reported these burdens could be alleviated by securing sufficient time to engage in HBOC management, creating easy-to-understand explanatory material for patients, collaboration with specialists in genetic medicine, and educational opportunities. CONCLUSION: Gynecologic oncologists in Japan are struggling to deal with psychological burdens in HBOC practice. To promote the clinical practice of HBOC management, there is an urgent need to strengthen human resources and improve educational opportunities, and expand insurance coverage for HBOC management.
format Online
Article
Text
id pubmed-9428299
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology; Japan Society of Gynecologic Oncology
record_format MEDLINE/PubMed
spelling pubmed-94282992022-09-07 Current status of hereditary breast and ovarian cancer practice among gynecologic oncologists in Japan: a nationwide survey by the Japan Society of Gynecologic Oncology (JSGO) Kobayashi, Yusuke Masuda, Kenta Hiraswa, Akira Takehara, Kazuhiro Tsuda, Hitoshi Watanabe, Yoh Oda, Katsutoshi Nagase, Satoru Mandai, Masaki Okamoto, Aikou Yaegashi, Nobuo Mikami, Mikio Enomoto, Takayuki Aoki, Daisuke Katabuchi, Hidetaka J Gynecol Oncol Original Article OBJECTIVE: The practices pertaining to hereditary breast and ovarian cancer (HBOC) in Japan have been rapidly changing owing to the clinical development of poly(ADP-ribose) polymerase inhibitors, the increasing availability of companion diagnostics, and the broadened insurance coverage of HBOC management from April 2020. A questionnaire of gynecologic oncologists was conducted to understand the current status and to promote the widespread standardization of future HBOC management. METHODS: A Google Form questionnaire was administered to the members of the Japan Society of Gynecologic Oncology. The survey consisted of 25 questions in 4 categories: respondent demographics, HBOC management experience, insurance coverage of HBOC management, and educational opportunities related to HBOC. RESULTS: A total of 666 valid responses were received. Regarding the prevalence of HBOC practice, the majority of physicians responded in the negative and required human resources, information sharing and educational opportunities, and expanded insurance coverage to adopt and improve HBOC practice. Most physicians were not satisfied with the educational opportunities provided so far, and further expansion was desired. They remarked on the psychological burdens of many HBOC managements. Physicians reported these burdens could be alleviated by securing sufficient time to engage in HBOC management, creating easy-to-understand explanatory material for patients, collaboration with specialists in genetic medicine, and educational opportunities. CONCLUSION: Gynecologic oncologists in Japan are struggling to deal with psychological burdens in HBOC practice. To promote the clinical practice of HBOC management, there is an urgent need to strengthen human resources and improve educational opportunities, and expand insurance coverage for HBOC management. Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology; Japan Society of Gynecologic Oncology 2022-07-18 /pmc/articles/PMC9428299/ /pubmed/35882604 http://dx.doi.org/10.3802/jgo.2022.33.e61 Text en © 2022. Asian Society of Gynecologic Oncology, Korean Society of Gynecologic Oncology, and Japan Society of Gynecologic Oncology https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Kobayashi, Yusuke
Masuda, Kenta
Hiraswa, Akira
Takehara, Kazuhiro
Tsuda, Hitoshi
Watanabe, Yoh
Oda, Katsutoshi
Nagase, Satoru
Mandai, Masaki
Okamoto, Aikou
Yaegashi, Nobuo
Mikami, Mikio
Enomoto, Takayuki
Aoki, Daisuke
Katabuchi, Hidetaka
Current status of hereditary breast and ovarian cancer practice among gynecologic oncologists in Japan: a nationwide survey by the Japan Society of Gynecologic Oncology (JSGO)
title Current status of hereditary breast and ovarian cancer practice among gynecologic oncologists in Japan: a nationwide survey by the Japan Society of Gynecologic Oncology (JSGO)
title_full Current status of hereditary breast and ovarian cancer practice among gynecologic oncologists in Japan: a nationwide survey by the Japan Society of Gynecologic Oncology (JSGO)
title_fullStr Current status of hereditary breast and ovarian cancer practice among gynecologic oncologists in Japan: a nationwide survey by the Japan Society of Gynecologic Oncology (JSGO)
title_full_unstemmed Current status of hereditary breast and ovarian cancer practice among gynecologic oncologists in Japan: a nationwide survey by the Japan Society of Gynecologic Oncology (JSGO)
title_short Current status of hereditary breast and ovarian cancer practice among gynecologic oncologists in Japan: a nationwide survey by the Japan Society of Gynecologic Oncology (JSGO)
title_sort current status of hereditary breast and ovarian cancer practice among gynecologic oncologists in japan: a nationwide survey by the japan society of gynecologic oncology (jsgo)
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9428299/
https://www.ncbi.nlm.nih.gov/pubmed/35882604
http://dx.doi.org/10.3802/jgo.2022.33.e61
work_keys_str_mv AT kobayashiyusuke currentstatusofhereditarybreastandovariancancerpracticeamonggynecologiconcologistsinjapananationwidesurveybythejapansocietyofgynecologiconcologyjsgo
AT masudakenta currentstatusofhereditarybreastandovariancancerpracticeamonggynecologiconcologistsinjapananationwidesurveybythejapansocietyofgynecologiconcologyjsgo
AT hiraswaakira currentstatusofhereditarybreastandovariancancerpracticeamonggynecologiconcologistsinjapananationwidesurveybythejapansocietyofgynecologiconcologyjsgo
AT takeharakazuhiro currentstatusofhereditarybreastandovariancancerpracticeamonggynecologiconcologistsinjapananationwidesurveybythejapansocietyofgynecologiconcologyjsgo
AT tsudahitoshi currentstatusofhereditarybreastandovariancancerpracticeamonggynecologiconcologistsinjapananationwidesurveybythejapansocietyofgynecologiconcologyjsgo
AT watanabeyoh currentstatusofhereditarybreastandovariancancerpracticeamonggynecologiconcologistsinjapananationwidesurveybythejapansocietyofgynecologiconcologyjsgo
AT odakatsutoshi currentstatusofhereditarybreastandovariancancerpracticeamonggynecologiconcologistsinjapananationwidesurveybythejapansocietyofgynecologiconcologyjsgo
AT nagasesatoru currentstatusofhereditarybreastandovariancancerpracticeamonggynecologiconcologistsinjapananationwidesurveybythejapansocietyofgynecologiconcologyjsgo
AT mandaimasaki currentstatusofhereditarybreastandovariancancerpracticeamonggynecologiconcologistsinjapananationwidesurveybythejapansocietyofgynecologiconcologyjsgo
AT okamotoaikou currentstatusofhereditarybreastandovariancancerpracticeamonggynecologiconcologistsinjapananationwidesurveybythejapansocietyofgynecologiconcologyjsgo
AT yaegashinobuo currentstatusofhereditarybreastandovariancancerpracticeamonggynecologiconcologistsinjapananationwidesurveybythejapansocietyofgynecologiconcologyjsgo
AT mikamimikio currentstatusofhereditarybreastandovariancancerpracticeamonggynecologiconcologistsinjapananationwidesurveybythejapansocietyofgynecologiconcologyjsgo
AT enomototakayuki currentstatusofhereditarybreastandovariancancerpracticeamonggynecologiconcologistsinjapananationwidesurveybythejapansocietyofgynecologiconcologyjsgo
AT aokidaisuke currentstatusofhereditarybreastandovariancancerpracticeamonggynecologiconcologistsinjapananationwidesurveybythejapansocietyofgynecologiconcologyjsgo
AT katabuchihidetaka currentstatusofhereditarybreastandovariancancerpracticeamonggynecologiconcologistsinjapananationwidesurveybythejapansocietyofgynecologiconcologyjsgo
AT currentstatusofhereditarybreastandovariancancerpracticeamonggynecologiconcologistsinjapananationwidesurveybythejapansocietyofgynecologiconcologyjsgo